Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Solid Phase Peptide Synthesis (SPPS). These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101792487A details a robust solid-phase method for Laterocidin. Overcomes extraction limits with high-purity cyclic peptide manufacturing capabilities.
Patent CN107880111B reveals a novel Glu-21 side-chain anchoring method for Liraglutide, enhancing coupling efficiency and purity for scalable manufacturing.
Patent CN107778350B details a high-yield solid-phase synthesis for Romidepsin, offering superior purity and cost reduction in pharmaceutical manufacturing.
Efficient fragment-based SPPS method for Nangibotide offering high purity and scalable manufacturing solutions for global pharmaceutical partners seeking reliable supply.
Novel solid-liquid hybrid method for Semaglutide fragments improves yield to 49% and purity to 99.9%, ensuring reliable supply chain.
Patent CN102020703A details a robust solid-phase synthesis for fatty acyl cyclic depsipeptides. This method offers high purity and scalability for antibiotic intermediate manufacturing.
Analyzing patent CN101712716A for Vapreotide production. Highlights solid-phase iodine oxidation for higher yield and cost reduction in API manufacturing.
Patent CN114276411B reveals a solid-phase method for trisulfide cyclic peptides. Achieve high purity and yield with scalable manufacturing for pharmaceutical intermediates.
Novel SPPS route for Setmelanotide offers >99% purity and scalable production for obesity treatment intermediates, ensuring reliable supply chain continuity.
Patent CN111944016B details a novel solid-phase synthesis using nitro-protection and dipeptide fragments for high-purity icatibant acetate manufacturing.
Advanced solid-phase synthesis of BPC 157 peptide using Fmoc strategy. High purity, scalable manufacturing process detailed in patent CN102229649B for reliable supply.
Patent CN107778353B reveals a novel MOBHA resin method for Terlipressin, achieving over 75% yield and superior purity compared to conventional Rink Amide processes.
Advanced solid-phase synthesis of Etelcalcetide via patent CN110054662B. Achieves >99.5% purity and 70% yield. Ideal for reliable API intermediate sourcing.
Patent CN106084015B reveals a breakthrough solid-phase method for carbetocin, achieving over 99.5% purity and significantly reducing impurities for reliable pharmaceutical intermediate sourcing.
Patent CN107778355B details a high-yield cetrorelix synthesis using novel MOBHA resin, offering significant cost and purity advantages for pharmaceutical manufacturers.
Patent CN112279891A details a novel solid-phase synthesis for Triptorelin using piperazine, offering high purity crude product and significant supply chain advantages for pharmaceutical manufacturers.
Patent CN102268082A details a novel solid-phase method for Ziconotide. This report analyzes cost reduction in peptide manufacturing and supply chain reliability.
Patent CN103374054B enables efficient one-step peptide synthesis. Discover cost reduction in peptide manufacturing and high-purity supply chain solutions.
Patent CN104017064B reveals high-purity teriparatide manufacturing with reduced oxidation impurities and scalable solid-phase synthesis protocols for global supply chains.
Novel fragment condensation method reduces impurities. Scalable lixisenatide manufacturing for pharmaceutical partners ensuring supply continuity.